Global solutions needed to better prioritize trials of repurposed drugs based on likelihood of scientific success, FDA’s Stein said. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
